首页> 外国专利> STRAIN OF BACTERIUM BRUCELLA ABORTUS USED FOR PREPARING DIAGNOSTIC AND PROPHYLACTIC BIOPREPARATIONS AGAINST BRUCELLOSIS IN ANIMALS

STRAIN OF BACTERIUM BRUCELLA ABORTUS USED FOR PREPARING DIAGNOSTIC AND PROPHYLACTIC BIOPREPARATIONS AGAINST BRUCELLOSIS IN ANIMALS

机译:布鲁氏菌菌株用于制备抗布鲁氏菌病的诊断性和益生菌生物制剂

摘要

FIELD: veterinary science, microbiology. SUBSTANCE: new strain of Brucella abortus N KB 13/100 is able to reproduce stably in nutrient media containing growth inhibitor of foreign microflora. Bis-triphenylanhydrocarbinol oxalate is used at concentration 0.001% as growth inhibitor. Strain shows high immunogenicity, expressed agglutinable and antigenic properties that are typical for brucella in S-form. Strain does not show pathogenicity for animals and humans. Strain Brucella abortus is deposited in microorganism collection of VGNKI at N KB 13/100 DEP. Diagnostic antigen prepared from the strain B. abortus VGNKI N KB 13/100 is the biopreparation showing high specificity and high activity and prepared vaccine shows high immunogenic activity. EFFECT: strain indicated above, valuable properties of biopreparation and vaccine. 4 tbl, 3 ex
机译:领域:兽医学,微生物学。物质:流产布鲁氏菌新菌株N KB 13/100能够在含有外来菌群生长抑制剂的营养培养基中稳定繁殖。草酸双三苯基氨基烃基草酸酯以0.001%的浓度用作生长抑制剂。菌株显示出高免疫原性,表达的可凝集和抗原性,这是布鲁氏菌S型的典型特征。菌株对动物和人类没有致病性。流产布鲁氏菌菌株以N KB 13/100 DEP沉积在VGNKI的微生物收集物中。由流产双歧杆菌VGNKI N KB 13/100制备的诊断抗原是显示出高特异性和高活性的生物制剂,并且制备的疫苗显示出高免疫原性活性。效果:上述菌株,生物制剂和疫苗的宝贵特性。 4汤匙,3前

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号